{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:17:13Z","timestamp":1790932633926,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/jac\/dki456","type":"journal-article","created":{"date-parts":[[2005,12,17]],"date-time":"2005-12-17T01:48:32Z","timestamp":1134784112000},"page":"353-355","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model"],"prefix":"10.1093","volume":"57","author":[{"given":"A.","family":"Baishanbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gargala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Favennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,12,16]]},"reference":[{"key":"key\n\t\t\t\t20171010211236_B1","doi-asserted-by":"crossref","unstructured":"Chen XM, LaRusso NF. Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy. Semin Liver Dis2002; 22: 277\u201389.","DOI":"10.1055\/s-2002-34505"},{"key":"key\n\t\t\t\t20171010211236_B2","doi-asserted-by":"crossref","unstructured":"Winkelstein JA, Marino MC, Ochs H et al. The X-linked Hyper IgM syndrome: clinical and immunological features of 79 patients. Medicine2003; 82: 373\u201384.","DOI":"10.1097\/01.md.0000100046.06009.b0"},{"key":"key\n\t\t\t\t20171010211236_B3","doi-asserted-by":"crossref","unstructured":"Forbes A, Blanshard C, Gazzard B. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut1993; 34: 116\u201321.","DOI":"10.1136\/gut.34.1.116"},{"key":"key\n\t\t\t\t20171010211236_B4","doi-asserted-by":"crossref","unstructured":"Hayward AR, Levy J, Facchetti F et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol1997; 158: 977\u201383.","DOI":"10.4049\/jimmunol.158.2.977"},{"key":"key\n\t\t\t\t20171010211236_B5","doi-asserted-by":"crossref","unstructured":"McLauchlin J, Amar CF, Pedraza-Diaz S et al. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Infect Dis J2003; 22: 329\u201335.","DOI":"10.1097\/01.inf.0000059402.81025.cd"},{"key":"key\n\t\t\t\t20171010211236_B6","doi-asserted-by":"crossref","unstructured":"Ko WF, Cello JP, Rogers SJ et al. Prognostic factors for the survival of patients with AIDS cholangiopathy. Am J Gastroenterol2003; 98: 2176\u201381.","DOI":"10.1111\/j.1572-0241.2003.07718.x"},{"key":"key\n\t\t\t\t20171010211236_B7","doi-asserted-by":"crossref","unstructured":"Goddard EA, Mouton SC, Westwood AT et al. Cryptosporidiosis of the gastrointestinal tract associated with sclerosing cholangitis in the absence of documented immunodeficiency: Cryptosporidium parvum and sclerosing cholangitis in an immunocompetent child. J Pediatr Gastroenterol Nutr2000; 31: 317\u201320.","DOI":"10.1097\/00005176-200009000-00023"},{"key":"key\n\t\t\t\t20171010211236_B8","doi-asserted-by":"crossref","unstructured":"White AC Jr, Chappell CL, Hayat CS et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis1994; 170: 419\u201324.","DOI":"10.1093\/infdis\/170.2.419"},{"key":"key\n\t\t\t\t20171010211236_B9","doi-asserted-by":"crossref","unstructured":"Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis2001; 184: 103\u20136.","DOI":"10.1086\/321008"},{"key":"key\n\t\t\t\t20171010211236_B10","doi-asserted-by":"crossref","unstructured":"Baishanbo A, Gargala G, Delaunay A et al. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils. Infect Immun2005; 73: 5252\u20135.","DOI":"10.1128\/IAI.73.8.5252-5255.2005"},{"key":"key\n\t\t\t\t20171010211236_B11","doi-asserted-by":"crossref","unstructured":"Roussel F, Favennec L, Lemeteil D et al. Biliary tract cryptosporidiosis immunosuppressed rat model. Int J Parasitol1996; 26: 19\u201324.","DOI":"10.1016\/0020-7519(95)00101-8"},{"key":"key\n\t\t\t\t20171010211236_B12","doi-asserted-by":"crossref","unstructured":"Verdon R, Polianski J, Gaudebout C et al. Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model. Antimicrob Agents Chemother1995; 39: 2155\u20137.","DOI":"10.1128\/AAC.39.9.2155"},{"key":"key\n\t\t\t\t20171010211236_B13","doi-asserted-by":"crossref","unstructured":"Li X, Brasseur P, Agnamey P et al. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol2003; 50: 19\u201322.","DOI":"10.14411\/fp.2003.003"},{"key":"key\n\t\t\t\t20171010211236_B14","doi-asserted-by":"crossref","unstructured":"Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev2002; 15: 145\u201354.","DOI":"10.1128\/CMR.15.1.145-154.2002"},{"key":"key\n\t\t\t\t20171010211236_B15","doi-asserted-by":"crossref","unstructured":"Blagburn BL, Drain KL, Land TM et al. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob Agents Chemother1998; 42: 2877\u201382.","DOI":"10.1128\/AAC.42.11.2877"},{"key":"key\n\t\t\t\t20171010211236_B16","doi-asserted-by":"crossref","unstructured":"Broekhuysen J, Stockis A, Lins RL et al. Nitazoxanide: pharmacokinetics and metabolism in man. Int J Clin Pharmacol Ther2000; 38: 387\u201394.","DOI":"10.5414\/CPP38387"},{"key":"key\n\t\t\t\t20171010211236_B17","doi-asserted-by":"crossref","unstructured":"Gargala G, Delaunay A, Li X et al. Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J Antimicrob Chemother2000; 46: 57\u201360.","DOI":"10.1093\/jac\/46.1.57"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/2\/353\/2408005\/dki456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T22:53:46Z","timestamp":1683327226000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/2\/353\/804743\/Efficacy-of-nitazoxanide-and-paromomycin-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,16]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,16]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki456","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,16]]}}}